Report of Objective Responses of Breast Cancer Patients to Pharmaceutical Grade Synthetic Cannabidiol


This report is an observational study of objective responses of Breast Cancer patients to Pharmaceutical Grade Synthetic Cannabidiol. There were 29 total cases out of which 27 showed a clinical response.

Click here for full text (external link)

Leave a Reply

Your email address will not be published. Required fields are marked *

Social media & sharing icons powered by UltimatelySocial